Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:40 PM
Ignite Modification Date:
2025-12-24 @ 3:40 PM
NCT ID:
NCT00405392
Eligibility Criteria:
Inclusion Criteria:
* Women with postmenopausal osteoporosis diagnosed by DXA scanning, defined by T-score of -2.5 SD at spine or femur.
* Patients who have never received bisphosphonates therapy (bisphosphonates naive)
Exclusion Criteria:
* Inability to stand or sit in the upright position for at least 60 minutes;
* Hypersensitivity to any component of risedronate and ibandronate;
* Administration of any investigational drug within 30 days preceding the first dose of the study drug;
* Patient has been on hormone (estrogen) replacement therapy or other osteoporosis medication (e.g. SERMS and calcitonin) within the previous 3 months.
* Patient has been on systemic corticosteroids therapy for more than 1 month within the past year.
* Other bone disease except osteoporosis
* Current medical history of uncontrolled major upper GI disease
Healthy Volunteers:
False
Sex:
FEMALE
Study:
NCT00405392
Study Brief:
Protocol Section:
NCT00405392